DM 18 | The percentage of patients with diabetes who have had influenza immunisation in the preceding 1 September to 31 March |
|
CHD 12 | The percentage of patients with coronary heart disease who have a record of influenza immunisation in the preceding 1 September to 31 March |
|
BP 5 | The percentage of patients with hypertension in whom the last blood pressure (measured in the last 9 months) is ≤150/90 mmHg |
|
CHD 10 | The percentage of patients with coronary heart disease who are currently treated with a beta-blocker (unless a contraindication or side-effects are recorded) |
|
Stroke 10 | The percentage of patients with TIA [transient ischaemic attack] or stroke who have had influenza immunisation in the preceding 1 September to 31 March |
|
DM 6 | The percentage of patients with diabetes in whom the last HbA1C is ≤7.4 (or equivalent test/reference range depending on local laboratory) in last 15 months |
|
CKD 3 | The percentage of patients on the CKD [chronic kidney disease] register in whom the last blood pressure reading, measured in the previous 15 months, is ≤140/85 mmHg |
|
COPD 8 | The percentage of patients with COPD who have had influenza immunisation in the preceding 1 September to 31 March |
|
CHD 9 | The percentage of patients with coronary heart disease with a record in the last 15 months that aspirin, an alternative antiplatelet therapy, or an anticoagulant is being taken (unless a contraindication or side-effects are recorded) |
|
AF3 | The percentage of patients with atrial fibrillation who are currently treated with anticoagulant drug therapy or an antiplatelet therapy. |
|
CHD 8 | The percentage of patients with coronary heart disease whose last measured total cholesterol (measured in last 15 months) is ≤5 mmol/l |
|
Stroke 9/12 | The percentage of patients with a stroke shown to be non-haemorrhagic, or a history of TIA, who have a record that aspirin, an alternative antiplatelet therapy, or an anticoagulant is being taken (unless a contraindication or side-effects are recorded) |
|
DM 12 | The percentage of patients with diabetes in whom the last blood pressure is ≤145/85 mmHg |
|
LVD 3 | The percentage of patients with a diagnosis of CHD and left ventricular dysfunction who are currently treated with ACE inhibitors (or A2 [angiotensin 2] antagonists) |
|
CHD 6 | The percentage of patients with coronary heart disease in whom the last blood pressure reading (measured in the last 15 months) is ≤150/90 mmHg |
|
Smoking 2 | The percentage of patients with any or any combination of the following conditions: CHD, stroke or TIA, hypertension, diabetes, COPD, or asthma who smoke, whose notes contain a record that smoking-cessation advice or referral to a specialist service, where available has been offered within the previous 15 months. |
|
Asthma 5 | The percentage of patients with asthma who smoke, and whose notes contain a record that smoking-cessation advice or referral to a specialist service, if available, has been offered within the last 15 months |
|
DM 7 | The percentage of patients with diabetes in whom the last HbA1C is ≤10 (or equivalent test/reference range depending on local laboratory) in last 15 months |
|
BP 3 | The percentage of patients with hypertension who smoke, whose notes contain a record that smoking-cessation advice or referral to a specialist service, if available, has been offered at least once |
|
DM 15 | The percentage of patients with diabetes with proteinuria or micro-albuminuria who are treated with ACE inhibitors (or A2 antagonists) |
|
COPD 5 | The percentage of patients with COPD who smoke, whose notes contain a record that smoking-cessation advice or referral to a specialist service, if available, has been offered in the past 15 months |
|
DM 4 | The percentage of patients with diabetes who smoke and whose notes contain a record that smoking-cessation advice or referral to a specialist service, where available, has been offered in the last 15 months |
|
CHD 4 | The percentage of patients with coronary heart disease who smoke, whose notes contain a record that smoking-cessation advice or referral to a specialist service, where available, has been offered within the last 15 months |
|
CHD 11 | The percentage of patients with a history of myocardial infarction (diagnosed after 1 April 2003) who are currently treated with an ACE inhibitor |
|
Stroke 4 | The percentage of patients with a history of TIA or stroke who smoke and whose notes contain a record that smoking-cessation advice or referral to a specialist service, if available, has been offered in the last 15 months |